Semaglutide Antidiabetic Drug and Risk of Vision Loss: Study Reveals
Sunday, 14 July 2024, 10:39
Semaglutide Study Reveals Increased Risk of Vision Loss
A recent study conducted by Boston researchers has linked the popular antidiabetic drug 'Semaglutide' to a heightened risk of vision loss.
Long-Term Side Effects and Vision Risks
Aside from its known long-term side effects, including heart diseases, the usage of Semaglutide has now been associated with potential vision loss risks.
- Conclusion: Users of Semaglutide should be aware of the increased risk of vision loss highlighted by this study.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.